CLINICAL_TRIALS
trial_result
· 2018-01-19
Clinical Trial Update: Neuroleptic and Huntington Disease Comparison of : Olanzapine, la Tetrabenazine and Tiapride [Phase 3]
Summary
A Phase 3 clinical trial comparing olanzapine, tetrabenazine, and tiapride for Huntington disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Huntington Disease | Phase 3 | Status: COMPLETED